March 16 was an active Merger Monday with a few large deals announced. Salix Pharmaceuticals Ltd. announced that it accepted an $11.1 billion takeover offer from Valeant Pharmaceuticals International Inc., leading rival bidder Endo International plc to withdraw its $175 per share offer.